Evidence map›Paper›PMID 40481332›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025

Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of life.

Emine Rabia Koc, Furkan Saridas, Mehmet Fatih Yetkin, Nuray Bilge, Yasemin Dinc, Emel Oguz Akarsu, Sarra Elhamida Lazrak, Sanja Gluscevic, Abdulkadir Tunc, Meral Seferoglu and 4 more

Abstract read
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Emine Rabia KocFaculty of Medicine, Department of Neurology, Bursa Uludag University, Uludag, Bursa, Turkey. erabiakoc@uludag.edu.tr.ORCID http://orcid.org/0000-0002-0264-7284
Furkan SaridasFaculty of Medicine, Department of Neurology, Bursa Uludag University, Uludag, Bursa, Turkey.
Mehmet Fatih YetkinFaculty of Medicine, Department of Neurology, Erciyes University, Kayseri, Turkey.
Nuray BilgeFaculty of Medicine, Department of Neurology, Atatürk University, Erzurum, Turkey.
Yasemin DincFaculty of Medicine, Department of Neurology, Bursa Uludag University, Uludag, Bursa, Turkey.
Emel Oguz AkarsuFaculty of Medicine, Department of Neurology, Bursa Uludag University, Uludag, Bursa, Turkey.
Sarra Elhamida LazrakFaculty of Medicine, Department of Neurology, Bursa Uludag University, Uludag, Bursa, Turkey.
Sanja GluscevicClinical Centre of Montenegro, Clinic for Neurology, Podgorica, Montenegro.
Abdulkadir TuncFaculty of Medicine, Department of Neurology, Sakarya University, Sakarya, Turkey.
Meral SeferogluBursa High Specialization Training and Research Hospital, Department of Neurology, Bursa, Turkey.
Caner BaydarFaculty of Medicine, Department of Neurology, Van Yüzüncü Yıl University, Van, Turkey.
Ali Ozhan SıvacıBursa High Specialization Training and Research Hospital, Department of Neurology, Bursa, Turkey.
O Faruk TuranFaculty of Medicine, Department of Neurology, Bursa Uludag University, Uludag, Bursa, Turkey.
Guven OzkayaFaculty of Medicine, Department of Biostatistics, Uludag University, Bursa, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein-associated disease (MOGAD) are autoimmune disorders frequently accompanied by chronic, often neuropathic, pain, which significantly impacts the quality of life, sleep, and mental health. This study evaluated the incidence and characteristics of neuropathic pain in 106 patients with NMOSD or MOGAD and assessed its effects on mental health, sleep quality, and overall quality of life. Using clinical evaluation and MRI findings to localize lesions, pain classification revealed that chronic pain was more common in NMOSD patients (78.4%) than in MOGAD patients (52.7%), with a significant impact on both groups. Patients with MOGAD who experienced neuropathic pain reported notably poorer sleep quality and higher anxiety and depression levels. Pain severity was strongly associated with spinal cord lesion length and thoracic location, particularly in MOGAD patients. Current treatments provide insufficient pain relief, highlighting the need for more effective management strategies. This study emphasized that neuropathic pain substantially diminishes both physical and mental well-being in NMOSD and MOGAD patients, highlighting the importance of personalized pain management approaches to improve quality of life and mental health in these populations.

Indexed as

Chronic PainMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseNeuralgiaNeuromyelitis OpticaQuality of LifeSleepAdultAgedFemaleHumansMaleMental HealthMiddle AgedMyelin-Oligodendrocyte GlycoproteinSleep Wake DisordersMyelin-Oligodendrocyte GlycoproteinMental healthMOGADNeuropathic painNMOSDPain managementQuality of life

Identifiers

PMID40481332
PMCPMC12394357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.